IGC PHARMA, INC. (IGC) Net margin 2016–2025
IGC PHARMA, INC. (IGC) net profit margin by fiscal year — reported net income divided by reported revenue.
-560.3%FY2025 · since FY2016: -44.1% → -560.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -560.3% | +406.2 pp |
| FY2024 | -966.5% | +296.5 pp |
| FY2023 | -1263.0% | +2519.4 pp |
| FY2022 | -3782.4% | -2801.2 pp |
| FY2021 | -981.2% | -801.5 pp |
| FY2020 | -179.6% | -99.6 pp |
| FY2019 | -80.1% | +1.4 pp |
| FY2018 | -81.4% | +240.3 pp |
| FY2017 | -321.7% | -277.6 pp |
| FY2016 | -44.1% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice